Navigation Links
Profil Institute Reaches Milestone in Early Phase Clinical Research for Diabetes
Date:8/26/2014

our research and was where we hoped to make the most significant impact on science and patient care.  Today we're pleased that through our commitment to science, clinical research and drug development, we have built the teams, infrastructure, technology and expertise that have allowed us to accumulate the knowledge and experience to benefit diabetes research as a whole."

Profil Institute is the only CRO in the U.S. therapeutically and scientifically focused exclusively on early phase diabetes and obesity clinical research and development.  Profil Institute has invested in its scientific expertise, including doctorate level scientists that make up more than 20% of Profil Institute's workforce, and in advancing its Automated Glucose Clamp technology and other key research methods.  The company's experience in early phase clinical studies includes every clinical relevant drug class, as well as nearly all modes of administration and blood glucose monitoring devices.  Of the 200 early phase clinical studies completed, 45% of those studies involved study participants with type 2 diabetes, 20% with type 1 diabetes, 20% with healthy study participants, and 15% involved specialized populations, including participants with cardiovascular disease, kidney disease or insulin resistance.

About Profil Institute for Clinical Research, Inc.

Profil Institute for Clinical Research, Inc. is a science driven, early phase clinical research organization (CRO) focused on diabetes and obesity.  It is renowned for its scientific expertise, depth of services, expanded scope of research methodologies, and experience with every clinically relevant drug class in diabetes.  The company provides end-to-end early phase services from consulting for strategic clinical development and regulatory planning through design and completion of complex clinical trials, including the reporting and publication of final study results.

Profil Institute'
'/>"/>

SOURCE Profil Institute for Clinical Research, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Masimo Announces New Low-Profile Infant and Neonatal Pulse Oximetry Sensors
2. Upsher-Smith Research Shows Unique Pharmacokinetic Profile of USL255 Extended Release Topiramate
3. Profil Institute Partners with Florida Hospital to Establish East Coast Center for Clinical Metabolic Research
4. Abaxis Announces the Launch of Kidney Profile Plus Panel
5. NKTR-192, A New Short-Acting Mu-Opioid Analgesic Molecule, Achieves Desired Pharmacokinetic Profile in First Phase 1a Clinical Study
6. Group Florence Nightingale Increases Radiosurgery Profile with Acquisition of Turkeys First Leksell Gamma Knife Perfexion System
7. Varian Medical Systems Selected by Leading Russian Development Foundations to Take Part in High-Profile Supplier Event
8. Medical Devices Research: Country Reports on Market Profile, Competitive Environment and more at RnRMarketResearch.com
9. High Profile HealthCare Companies: Leading Pharma Company Secures New Patents
10. Upsher-Smith Presents Data Supporting Favorable Tolerability And Consistent Pharmacokinetic Profile Of Once-Daily USL255 (Extended-Release Topiramate)
11. Fortune Magazine Profiles ArcView Group, Co-founded by Steve DeAngelo
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... BURLINGTON, Mass. , Sept. 18, 2014 /PRNewswire/ ... post-launch in the United States ... have prescribed GlaxoSmithKline,s BRAF inhibitor Tafinlar for ... 49 percent who have prescribed GlaxoSmithKline,s MEK inhibitor ... the highest percentage (42 percent and 43 percent, ...
(Date:9/18/2014)... 18, 2014  Iliad Neurosciences, Inc., a company focused ... treating Autism Spectrum Disorders (ASD) announced today that it ... Research Foundation for The State University of New York. ... new biomarker to identify an abnormality in folate transport ... biomarker is expected to be available for research use ...
(Date:9/18/2014)... BURLINGTON, Mass. , Sept. 18, 2014  Decision ... launched anti-vascular endothelial growth factor (VEGF) agent for wet ... and Medicare Advantage plans as Genentech,s Lucentis, which is ... although surveyed managed care organization (MCO) directors do not ... Eylea is slightly more likely than Lucentis to be ...
Breaking Medicine Technology:At One Year Post-Launch, Approximately One Half of Surveyed U.S. Medical Oncologists Have Prescribed Single-Agent Tafinlar and Mekinist to Their Malignant Melanoma Patients 2Iliad Neurosciences, Inc. enters into an Exclusive License Agreement with The Research Foundation for The State University of New York 2Iliad Neurosciences, Inc. enters into an Exclusive License Agreement with The Research Foundation for The State University of New York 3Regeneron's Eylea and Genentech's Lucentis Are Equally Likely to be Covered on Commercial and Medicare Advantage Plans for Wet AMD 2Regeneron's Eylea and Genentech's Lucentis Are Equally Likely to be Covered on Commercial and Medicare Advantage Plans for Wet AMD 3
(Date:9/18/2014)... (PRWEB) September 18, 2014 Memorial ... made history this week by performing the first ever, ... UNOS (United Network for Organ Sharing) approval to launch ... one of only two programs in South Florida. ... Dr. Enrique Gongora, Medical Director of the ...
(Date:9/18/2014)... -- Older people become more physically vulnerable during bereavement, ... stress hormones during bereavement changes with age, British researchers ... are more likely to have weakened immune systems and ... weeks and months after loss, we can suffer from ... of white blood cell and as such are essential ...
(Date:9/18/2014)... One of the most capable and ... ShandsCair Flight Program’s new EC155 B1, will ... at the Air Medical Transport Conference (AMTC), Sept. 22-24, ... into service ShandsCair EC155 and the Vanderbilt University ... AMTC highlight Airbus Helicopters broad, industry leading line-up of ...
(Date:9/18/2014)... -- Daily supplements of selenium or vitamin E don,t ... cataracts among men, a new study indicates. Previous ... help prevent cataracts. To investigate this further, William Christen, ... in Boston, and his colleagues examined data from a ... trial was initially designed to study prevention of prostate ...
(Date:9/18/2014)... Thousands of college and high school ... fundraising impact on 127 member Children’s Miracle Network ... Dance Marathon Day will officially kick off a school ... raised by college and high school students funding vital ... Dance Marathon campus programs help provide medical equipment, treatment ...
Breaking Medicine News(10 mins):Health News:Memorial Cardiac & Vascular Institute Performs First Adult Heart Transplant in Broward County 2Health News:Memorial Cardiac & Vascular Institute Performs First Adult Heart Transplant in Broward County 3Health News:Memorial Cardiac & Vascular Institute Performs First Adult Heart Transplant in Broward County 4Health News:Grief Can Weigh on Immune System in Older Folks, Study Says 2Health News:Airbus Helicopters Inc. Features Industry-leading Models at AMTC 2Health News:Airbus Helicopters Inc. Features Industry-leading Models at AMTC 3Health News:Airbus Helicopters Inc. Features Industry-leading Models at AMTC 4Health News:Vitamin E, Selenium Supplements Don't Seem to Prevent Cataracts 2Health News:250 Campuses Usher in School Year of Saving Kids’ Lives During First-Ever “Dance Marathon Day” on Sept. 25 2
... ... Locally, , ... WA (PRWEB) July 2, 2010 -- Bill the Butcher Inc. opened a neighborhood butcher ... executive officer., , ,Located at 3800 34th Ave West in Seattle,s Magnolia neighborhood, the ...
... patients with Hodgkin lymphoma (HL) and a history of heart ... after completing treatment, according to research published online today in ... Hematology. HL is a form of cancer of arising in ... the disease in 2009, according to the American Cancer Society. ...
... at Karolinska Institutet recommends a new routine for protection ... for feeding directly through the abdominal wall, is surgically ... simpler and cheaper than the one used today. The ... has been clinically tested on over 200 patients at ...
... Register now for ... of women, at the Mariandale Retreat Center -- right outside of NYC, which will be held ... workshops, room and board, is only $350 until July 9, 2010. , ... New York, NY (PRWEB) July 2, 2010 -- Need to get ...
... ... is pleased to announce the Grand Opening of their newly expanded pain treatment center in ... ... are located at 638 West Duarte Road, Suite 18, Arcadia, California 91007. The Los Angeles ...
... ... , ... 1, 2010-- Aromatherapy isn’t new to the field of natural health. Ancient Egyptians were the ... the Romans to modern day, essential oils have been part of a holistic approach to ...
Cached Medicine News:Health News:In Time for July 4th Grilling, Bill the Butcher Opens 5th Butcher Shop 2Health News:Lymphoma patients with cardiovascular disease have increased risk of cardiac hospitalization 2Health News:Simpler and cheaper antibiotic prophylaxis with insertion of nutrition catheter in the stomach 2Health News:Relax, Release and Rejuvenate at Upcoming Women's Retreat 2Health News:Relax, Release and Rejuvenate at Upcoming Women's Retreat 3Health News:Advanced Pain Institute Opens Expanded Los Angeles Area Pain Management Center 2Health News:Certified Organic Aromatherapy Oils Available from Swanson Health Products 2
... An APTT-based kit for the screening of ... specificity of the test for the factor ... sample plasma with an excess of V-DEF ... possible to discriminate between heterozygous and homozygous ...
Inquire...
Inquire...
... remarkable anti-reflux valve is enclosed ... which prevents the valve from ... in sitting or reclining positions. ... and interference free ensuring uninterrupted ...
Medicine Products: